KeyCorp Cuts UnitedHealth Group (NYSE:UNH) Price Target to $400.00

UnitedHealth Group (NYSE:UNH - Free Report) had its price objective reduced by KeyCorp from $450.00 to $400.00 in a research report report published on Monday morning,Benzinga reports. They currently have an overweight rating on the healthcare conglomerate's stock.

Other equities analysts also recently issued research reports about the company. JPMorgan Chase & Co. decreased their target price on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. Truist Financial reissued a "buy" rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Finally, TD Securities reissued a "hold" rating and set a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $428.43.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded down $3.29 during midday trading on Monday, hitting $301.43. 12,750,928 shares of the company's stock were exchanged, compared to its average volume of 6,877,533. The business's fifty day moving average price is $426.60 and its two-hundred day moving average price is $490.74. The company has a market cap of $273.44 billion, a price-to-earnings ratio of 19.45, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the firm posted $6.91 EPS. As a group, research analysts forecast that UnitedHealth Group will post 29.54 EPS for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is currently owned by insiders.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors have recently modified their holdings of UNH. NewSquare Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $28,000. Bayforest Capital Ltd lifted its stake in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares during the period. Finally, Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.